Two Sigma Advisers
CATX icon

Two Sigma Advisers’s Perspective Therapeutics CATX Stock Holding History

Two Sigma Advisers’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-663,830
Closed -$1.83M – 369
2025
Q4 		$1.83M Buy
663,830
+258,200
+64% +$737K ﹤0.01% 1225
2025
Q3 		$1.39M Sell
405,630
-89,620
-18% -$327K ﹤0.01% 1303
2025
Q2 		$1.7M Buy
495,250
+249,800
+102% +$659K ﹤0.01% 1200
2025
Q1 		$523K Buy
245,450
+93,840
+62% +$282K ﹤0.01% 1758
2024
Q4 		$484K Buy
+151,610
New +$1.24M ﹤0.01% 1789
2024
Q2 		– Sell
-2,310
Closed -$27.5K – 2464
2024
Q1 		$27.5K Sell
2,310
-930
-29% -$7.93K ﹤0.01% 2385
2023
Q4 		$13K Sell
3,240
-20
-0.6% -$56 ﹤0.01% 2463
2023
Q3 		$8.92K Sell
3,260
-360
-10% -$1.68K ﹤0.01% 2347
2023
Q2 		$24.2K Sell
3,620
-560
-13% -$3.4K ﹤0.01% 2319
2023
Q1 		$26.7K Sell
4,180
-270
-6% -$1.1K ﹤0.01% 2501
2022
Q4 		$11K Hold
4,450
– – ﹤0.01% 2456
2022
Q3 		$10K Sell
4,450
-990
-18% -$3.39K ﹤0.01% 2480
2022
Q2 		$17K Sell
5,440
-1,140
-17% -$3.48K ﹤0.01% 2561
2022
Q1 		$24K Buy
6,580
+2,620
+66% +$9.55K ﹤0.01% 2653
2021
Q4 		$15K Buy
+3,960
New +$21.1K ﹤0.01% 2557
2021
Q2 		– Sell
-5,170
Closed -$56K – 2468
2021
Q1 		$56K Buy
+5,170
New +$78.1K ﹤0.01% 2494

Other funds holding CATX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Advisers's CATX Position: Q1 2026 in Review

Two Sigma Advisers sold out of Perspective Therapeutics (CATX) in Q1 2026, closing a stake of 663,830 shares — an estimated $1.83M sold.

Two Sigma Advisers first reported a position in CATX in Q1 2021 and held it in 16 quarters. The position peaked at $1.83M in Q4 2025. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • Two Sigma Advisers reported no remaining Perspective Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 663,830 Perspective Therapeutics shares in Q1 2026, an estimated $1.83M.
  • Two Sigma Advisers first reported a position in Perspective Therapeutics in Q1 2021 and held it in 16 quarters.
  • Two Sigma Advisers's Perspective Therapeutics position peaked at $1.83M in Q4 2025.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.